CNTB
Connect Biopharma Holdings Ltd
NASDAQ · Healthcare · Biotechnology · CN
$1.28
−0.78%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.27
- Revenue estimate
- $115.5K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.27
- EPS estimate
- -$0.31
- Revenue actual
- $2.7M
- Revenue estimate
- $743.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +0.6%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $7.60
- PT range
- $6.00 – $10
- Analysts
- 5
5 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.31 | -$0.27 | Beat 14.26% | $2.7M |
| May 12, 2026 | -$0.29 | -$0.34 | Miss -17.24% | $24.5K |
| Mar 31, 2026 | -$0.30 | -$0.27 | Beat 10.00% | $16.0K |
| Aug 13, 2025 | -$0.22 | -$0.23 | Miss -4.55% | $6.7K |
| Mar 31, 2025 | -$0.27 | -$0.06 | Beat 78.66% | $261.9K |
| Sep 5, 2024 | -$0.03 | $0.02 | Beat 167.49% | $3.3M |
| Apr 16, 2024 | -$0.03 | -$0.07 | Miss -131.68% | — |
| Sep 12, 2023 | -$6.92 | -$0.08 | Beat 98.89% | — |
| Apr 11, 2023 | -$3.58 | -$0.15 | Beat 95.80% | — |
| Sep 13, 2022 | -$5.28 | -$0.16 | Beat 96.93% | — |
| Mar 31, 2022 | -$4.38 | -$0.17 | Beat 96.22% | — |
| Aug 31, 2021 | -$2.36 | -$0.48 | Beat 79.66% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026